Fresenius Medical Care AG & Co. KGaA

Transaction in Own Shares • Dec 27, 2017

News Details

Other Capital Market Information | 27 December 2017 16:48

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Article 5
(1) (b), (3) of Regulation (EU) No 596/2014 and Article 2 (3) of Delegated
Regulation (EU) No 2016/1052

27.12.2017 / 16:48
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

Announcement pursuant to Article 5 (1) (b), (3) of Regulation (EU) No
596/2014 and Article 2 (3) of Delegated Regulation (EU) No 2016/1052

• Share buy-back - 2nd Interim Report and Final Report

In the period from 18 December 2017 until and including 21 December 2017, a
total of 221,425 shares were repurchased within the framework of the share
buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius
Medical Care'), which was announced on 8 December 2017 pursuant to Article
5 (1) (a) of Regulation (EU) No 596/2014 and Article 2 (1) of Delegated
Regulation (EU) No 2016/1052.

Day of repurchase Aggregated volume in Weighted average share
number of shares price in EUR
December 18, 2017 74,879 88.2222
December 19, 2017 74,389 87.9080
December 20, 2017 71,403 87.5432
December 21, 2017 754 87.2622

The total volume of shares repurchased within the framework of this share
buy-back in the period from 11 December until and including 21 December
2017 therefore amounts to 660,000 shares. The weighted average share price
paid for these shares amounted to EUR 87.7788. This concludes the share
buy-back programme.

The purchase of shares of Fresenius Medical Care within the framework of
the share buy-back programme was carried out exclusively on the Frankfurt
Stock Exchange via the XETRA trading platform by a credit institution
commissioned by Fresenius Medical Care.

Detailed information on the transactions pursuant to Article 2 (3) of
Delegated Regulation (EU) No 2016/1052 is available on Fresenius Medical
Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA

represented by Fresenius Medical Care Management AG

represented by its Management Board

Bad Homburg v.d.H., 27 December 2017

---

27.12.2017 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---

 Language:    English
 Company:     Fresenius Medical Care AG & Co. KGaA
              Else-Kröner-Straße 1
              61352 Bad Homburg
              Germany
 Internet:    www.freseniusmedicalcare.com



 End of News    DGAP News Service